Ekberg and colleagues proposed that in type 1 diabetes a deficiency of C peptide, a subunit of the proinsulin molecule, also contributes to nerve damage; their animal studies showed that C-peptide ...
Hosted on MSN2mon
Sana Biotech Stock Triples After Type 1 Diabetes Trial Wows Analysts: Retail Erupts In ExcitementFour weeks after transplantation, the study showed the survival and function of transplanted pancreatic beta cells, evidenced by circulating C-peptide levels, which indicate insulin production.
SEATTLE, March 17, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today reported financial results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results